http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1638521-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 2004-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_836216669a8f79f1cbffe85f5813861d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_693900f20e513da8e6f63314fb358955 |
publicationDate | 2006-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1638521-A1 |
titleOfInvention | Transmucosal form of administration with reduced mucosal irritation |
abstract | The invention relates to film-type forms of administration for the transmucosal administration of active ingredients to the human or animal body. Said forms of administration are characterised by an adaptation or approach of the pH value of the base mass used to produce the form of administration and comprising a solvent or a solvent mixture, at least one matrix-forming polymer and at least one active ingredient, to the physiological pH value of the mucosa for the application. The invention also relates to a method for producing such preparations and to the use of the same as forms of administration, especially for pharmaceutical active ingredients, in such a way that mucosal irritation is reduced or even prevented by the application of the resulting forms of administration. |
priorityDate | 2003-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.